ACE2 and viral infectious disease: However, ACE2 inhibitors did not significantly improve the prognosis of COVID-19 patients, and the expression level of ACE2 in the kidney decreased significantly after viral infection, which suggested that there may be other receptors of SARS-CoV-2 in the kidney.